These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 25981754)

  • 1. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Technology in the Discovery and Development of Novel Antibacterials.
    Chung PY
    Curr Drug Targets; 2018; 19(7):832-840. PubMed ID: 28891454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobiotechnological Approaches Against Multidrug Resistant Bacterial Pathogens: An Update.
    Shaikh S; Shakil S; Abuzenadah AM; Rizvi SM; Roberts PM; Mushtaq G; Kamal MA
    Curr Drug Metab; 2015; 16(5):362-70. PubMed ID: 26419545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibiotic resistance crisis, with a focus on the United States.
    Martens E; Demain AL
    J Antibiot (Tokyo); 2017 May; 70(5):520-526. PubMed ID: 28246379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense RNA regulation and application in the development of novel antibiotics to combat multidrug resistant bacteria.
    Ji Y; Lei T
    Sci Prog; 2013; 96(Pt 1):43-60. PubMed ID: 23738437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategies for combating multidrug-resistant bacteria.
    Wright GD; Sutherland AD
    Trends Mol Med; 2007 Jun; 13(6):260-7. PubMed ID: 17493872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counteracting antibiotic resistance: breaking barriers among antibacterial strategies.
    Baquero F; Coque TM; Cantón R
    Expert Opin Ther Targets; 2014 Aug; 18(8):851-61. PubMed ID: 24881465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging drugs for acute bacterial skin and skin structure infections: an update.
    Kollipara R; Downing C; Lee M; Guidry J; Curtis S; Tyring S
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):431-40. PubMed ID: 25146459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unmet medical needs in antibacterial therapy.
    Rice LB
    Biochem Pharmacol; 2006 Mar; 71(7):991-5. PubMed ID: 16280121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance in the intensive care unit: mechanisms, epidemiology, and management of specific resistant pathogens.
    Fraimow HS; Tsigrelis C
    Crit Care Clin; 2011 Jan; 27(1):163-205. PubMed ID: 21144992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance in bacteria and its future for novel antibiotic development.
    Yoneyama H; Katsumata R
    Biosci Biotechnol Biochem; 2006 May; 70(5):1060-75. PubMed ID: 16717405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Emergence pathogens infections in ENT Department of Children's hospital in 2005-2008].
    Zielnik-Jurkiewicz B; Rakowska-Szkudlarek M
    Otolaryngol Pol; 2009; 63(6):513-9. PubMed ID: 20198987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid antibiotics - clinical progress and novel designs.
    Parkes AL; Yule IA
    Expert Opin Drug Discov; 2016 Jul; 11(7):665-80. PubMed ID: 27169483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
    Payne D; Tomasz A
    Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to antibiotics: are we in the post-antibiotic era?
    Alanis AJ
    Arch Med Res; 2005; 36(6):697-705. PubMed ID: 16216651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in antibacterial applications of metal nanoparticles (MNPs) and metal nanocomposites (MNCs) against multidrug-resistant (MDR) bacteria.
    Alavi M; Rai M
    Expert Rev Anti Infect Ther; 2019 Jun; 17(6):419-428. PubMed ID: 31046483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 46.